C WorldWide Group Holding A S cut its holdings in UnitedHealth Group Inc (NYSE:UNH) by 3.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 158,916 shares of the healthcare conglomerate’s stock after selling 5,688 shares during the period. UnitedHealth Group comprises approximately 0.5% of C WorldWide Group Holding A S’s investment portfolio, making the stock its 20th biggest holding. C WorldWide Group Holding A S’s holdings in UnitedHealth Group were worth $42,278,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. WoodTrust Financial Corp boosted its position in shares of UnitedHealth Group by 2.5% in the third quarter. WoodTrust Financial Corp now owns 7,823 shares of the healthcare conglomerate’s stock valued at $2,081,000 after acquiring an additional 189 shares during the period. Advisors Capital Management LLC boosted its position in shares of UnitedHealth Group by 15.2% in the third quarter. Advisors Capital Management LLC now owns 1,437 shares of the healthcare conglomerate’s stock valued at $382,000 after acquiring an additional 190 shares during the period. Chicago Partners Investment Group LLC lifted its position in UnitedHealth Group by 26.5% during the second quarter. Chicago Partners Investment Group LLC now owns 920 shares of the healthcare conglomerate’s stock worth $226,000 after purchasing an additional 193 shares during the period. Highland Capital Management LLC lifted its position in UnitedHealth Group by 0.5% during the third quarter. Highland Capital Management LLC now owns 36,128 shares of the healthcare conglomerate’s stock worth $9,612,000 after purchasing an additional 194 shares during the period. Finally, OLD Mutual Customised Solutions Proprietary Ltd. lifted its position in UnitedHealth Group by 1.2% during the second quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 17,096 shares of the healthcare conglomerate’s stock worth $4,194,000 after purchasing an additional 200 shares during the period. Institutional investors own 85.57% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the transaction, the director now owns 1,720,112 shares of the company’s stock, valued at $453,094,701.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Steven H. Nelson sold 8,142 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the transaction, the chief executive officer now directly owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,395 shares of company stock valued at $9,186,302. Insiders own 0.87% of the company’s stock.

NYSE UNH traded down $7.67 during trading on Friday, hitting $269.18. 3,506,856 shares of the company’s stock were exchanged, compared to its average volume of 3,476,123. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61. The company has a market cap of $266.34 billion, a price-to-earnings ratio of 26.73, a PEG ratio of 1.59 and a beta of 0.76. UnitedHealth Group Inc has a fifty-two week low of $208.48 and a fifty-two week high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The business’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.66 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Inc will post 12.82 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.34%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s payout ratio is 35.75%.

Several equities research analysts recently weighed in on the stock. BMO Capital Markets upped their price objective on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, November 21st. Piper Jaffray Companies upped their price objective on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 17th. Raymond James upped their price objective on shares of UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, October 17th. Finally, Royal Bank of Canada upped their price objective on shares of UnitedHealth Group to $308.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 17th. Two research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $292.48.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.mareainformativa.com/news/2018/12/08/unitedhealth-group-inc-unh-shares-sold-by-c-worldwide-group-holding-a-s-updated-updated-updated.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: How does the Federal Reserve determine interest rates?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.